Christos Liaskos

2.5k total citations
78 papers, 1.9k citations indexed

About

Christos Liaskos is a scholar working on Epidemiology, Rheumatology and Hepatology. According to data from OpenAlex, Christos Liaskos has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 34 papers in Rheumatology and 29 papers in Hepatology. Recurrent topics in Christos Liaskos's work include Systemic Lupus Erythematosus Research (25 papers), Liver Diseases and Immunity (22 papers) and Liver Disease Diagnosis and Treatment (19 papers). Christos Liaskos is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Liver Diseases and Immunity (22 papers) and Liver Disease Diagnosis and Treatment (19 papers). Christos Liaskos collaborates with scholars based in Greece, Germany and United Kingdom. Christos Liaskos's co-authors include Dimitrios P. Bogdanos, Eirini I. Rigopoulou, Lazaros I. Sakkas, Kalliopi Zachou, Αthanasios Mavropoulos, George Ν. Dalekos, Nikolaos Gatselis, Theodora Simopoulou, Christina Katsiari and George N. Dalekos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Scientific Reports.

In The Last Decade

Christos Liaskos

76 papers receiving 1.8k citations

Peers

Countries citing papers authored by Christos Liaskos

Since Specialization

Citations

This map shows the geographic impact of Christos Liaskos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Liaskos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Liaskos more than expected).

Fields of papers citing papers by Christos Liaskos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos Liaskos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Liaskos. The network helps show where Christos Liaskos may publish in the future.

Co-authorship network of co-authors of Christos Liaskos

This figure shows the co-authorship network connecting the top 25 collaborators of Christos Liaskos. A scholar is included among the top collaborators of Christos Liaskos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos Liaskos. Christos Liaskos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening and diagnosis of sarcopenia in rheumatic and musculoskeletal diseases: findings from a cross-sectional study 2025 ·Rheumatology International ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christos Liaskos, (unknown), (unknown), Ioannis Alexiou, Theodora Simopoulou, Sousana Κ. Papadopoulou, Christina Katsiari, Efterpi Zafiriou, Dimitrios G. Goulis, Dimitrios P. Bogdanos, Maria G. Grammatikopoulou	3
2	Clinical Profile and Outcomes in Anti-TIF1γ Positive Idiopathic Inflammatory Myositis Patients: A Greek Cohort Study 2025 ·Mediterranean Journal of Rheumatology ·(unknown), Christos Liaskos, (unknown), Ioannis Alexiou, Theodora Simopoulou, Christina Katsiari, Dimitrios P. Bogdanos	0
3	Effect of Crocus sativus (Saffron) Intake on Top of Standard Treatment, on Disease Outcomes and Comorbidities in Patients with Rheumatic Diseases: Synthesis without Meta-Analysis (SWiM) and Level of Adherence to the CONSORT Statement for Randomized Controlled Trials Delivering Herbal Medicine Interventions 2021 ·Nutrients ·(unknown), Maria G. Grammatikopoulou, Konstantinos Gkiouras, Efterpi Zafiriou, (unknown), Christos Liaskos, Efthimios Dardiotis, Lazaros I. Sakkas, Dimitrios P. Bogdanos	10
4	Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis 2021 ·Frontiers in Immunology ·(unknown), Αthanasios Mavropoulos, Efthimios Dardiotis, Vana Tsimourtou, Vasileios Siokas, Athina‐Maria Aloizou, Christos Liaskos, Christina Tsigalou, Christina Katsiari, Lazaros I. Sakkas, Georgios M. Hadjigeorgiou, Dimitrios P. Bogdanos	11
5	A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies 2020 ·Rheumatology International ·(unknown), Christos Liaskos, Theodora Simopoulou, Christina Katsiari, (unknown), Thomas Scheper, Wolfgang Meyer, Alexandra Tsirogianni, Christina Tsigalou, Efthimios Dardiotis, Dimitrios Daoussis, Lazaros I. Sakkas, Dimitrios P. Bogdanos	5
6	A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis 2019 ·Clinical Immunology ·(unknown), Efthimios Dardiotis, Christos Liaskos, (unknown), Thomas Scheper, Wolfgang Meyer, Alexandros Daponte, Dimitrios Daoussis, Georgios M. Hadjigeorgiou, Dimitrios P. Bogdanos, Lazaros I. Sakkas	19
7	Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis 2018 ·Frontiers in Immunology ·(unknown), Christos Liaskos, Maria Mytilinaiou, Theodora Simopoulou, Christina Katsiari, Alexandra Tsirogianni, Dimitrios Daoussis, Thomas Scheper, Wolfgang Meyer, Dimitrios P. Bogdanos, Lazaros I. Sakkas	12
8	Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis 2017 ·Scientific Reports ·(unknown), Efthimios Dardiotis, Christos Liaskos, (unknown), Vana Tsimourtou, Eirini I. Rigopoulou, Thomas Scheper, Alexandros Daponte, Wolfgang Meyer, Lazaros I. Sakkas, Georgios M. Hadjigeorgiou, Dimitrios P. Bogdanos	22
9	IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNγ-producing T cells 2017 ·Clinical Immunology ·Αthanasios Mavropoulos, (unknown), Efterpi Zafiriou, Christos Liaskos, Ioannis Alexiou, (unknown), Marianna Vlychou, Christina Katsiari, Dimitrios P. Bogdanos, Lazaros I. Sakkas	59
10	Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases 2017 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Sofia Farkona, Antoninus Soosaipillai, Panagiota S. Filippou, Christos Liaskos, Dimitrios P. Bogdanos, Eleftherios P. Diamandis, Ivan M. Blasutig	9
11	Disease-related autoantibody profile in patients with systemic sclerosis 2017 ·Autoimmunity ·Christos Liaskos, (unknown), Theodora Simopoulou, (unknown), (unknown), Thomas Scheper, Wolfgang Meyer, Dimitrios P. Bogdanos, Lazaros I. Sakkas	74
12	Crohn's disease-specific anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis 2015 ·Clinics and Research in Hepatology and Gastroenterology ·Christos Liaskos, Vassiliki Spyrou, Labrini V. Athanasiou, Timoklia Orfanidou, Αthanasios Mavropoulos, Eirini I. Rigopoulou, G.S. Amiridis, Yehuda Shoenfeld, Charalambos Billinis, Dimitrios P. Bogdanos	2
13	IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases 2008 ·Journal of Clinical Immunology ·Stella Gabeta, Gary L. Norman, Nikolaos Gatselis, Christos Liaskos, Panagiotis Papamichalis, (unknown), Kalliopi Zachou, Eirini I. Rigopoulou, George N. Dalekos	35
14	Six Mantoux tuberculin skin tests with 1, 2, 5, 10, 20, and 50 units in a healthy male without side-effects – is skin reaction a linear function of tuberculin dose? 2008 ·Cases Journal ·Ioannis Dimoliatis, Christos Liaskos	5
15	[452] CHRONIC HEPATITIS C IS CHARACTERISED BY AN 2007 ·Journal of Hepatology ·Christos Liaskos, Dimitrios P. Bogdanos, Nikolaos Gatselis, (unknown), Zakera Shums, Diane K. Murphy, Eirini I. Rigopoulou, Heather M. Smith, Diego Vergani, (unknown), (unknown)	1
16	Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis 2007 ·Journal of Clinical Immunology ·Stella Gabeta, Gary L. Norman, Christos Liaskos, Panagiotis Papamichalis, Theodoros Zografos, (unknown), Eirini I. Rigopoulou, George N. Dalekos	52
17	Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis 2005 ·Gut ·(unknown), (unknown), Albert Parés, (unknown), Christos Liaskos, Dimitrios P. Bogdanos, Joan Rodés, (unknown), Diego Vergani	112
18	HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece 2005 ·Journal of Clinical Virology ·Eirini I. Rigopoulou, Ioannis Stefanidis, Christos Liaskos, Eleftheria Zervou, Christos V. Rizos, (unknown), Kalliopi Zachou, (unknown), (unknown), George Kyriakopoulos, (unknown), (unknown), George Ν. Dalekos	33
19	Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis 2005 ·Journal of Autoimmunity ·Christos Liaskos, Eirini I. Rigopoulou, (unknown), S. P. Georgiadou, Nikolaos Gatselis, (unknown), (unknown)	38
20	Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase 2004 ·European Journal of Gastroenterology & Hepatology ·Kalliopi Zachou, Eirini I. Rigopoulou, Christos Liaskos, Kalliopi Patsiaoura, (unknown), N. Stathakis, George Ν. Dalekos	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact